SEC Form 3 · accession 0000899243-18-025597
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Noble
Director
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 6:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 27,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $0.0013 | holding | — | — | — | Dec 29, 2018 | Dec 29, 2025 | Ordinary Shares | 14,479 | — | D |
| Stock OptionsF1,F2 | $4.9867 | holding | — | — | — | Dec 29, 2018 | Dec 29, 2025 | Ordinary Shares | 34,061 | — | D |
| Stock OptionsF1,F2 | $4.9867 | holding | — | — | — | Dec 29, 2018 | Dec 29, 2025 | Ordinary Shares | 34,061 | — | D |
| Stock OptionsF1,F2 | $0.0013 | holding | — | — | — | Jan 6, 2020 | Jan 6, 2027 | Ordinary Shares | 9,168 | — | D |
| Stock OptionsF1,F3 | $9.8117 | holding | — | — | — | Jan 6, 2020 | Jan 6, 2027 | Ordinary Shares | 18,636 | — | D |
| Stock OptionsF1,F2 | $0.0013 | holding | — | — | — | Jan 3, 2021 | Jan 3, 2028 | Ordinary Shares | 10,740 | — | D |
| Stock OptionsF1,F3 | $11.1741 | holding | — | — | — | Jan 3, 2021 | Jan 3, 2028 | Ordinary Shares | 17,676 | — | D |
Explanation of responses
- F1Granted pursuant to the Issuer's Long-Term Incentive Plan.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.302 U.S. Dollars as of September 28, 2018.
- F3The reported options are options to purchase American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.